Ochre Bio Company
Ochre Bio is developing therapies for the biggest liver health challenges.
Investors
.png)
Connections from
Employee Number:
11-50
Investors Number:
19.0
Funding Status:
Early Stage Venture
Headquarters:
Oxford, Oxfordshire, United Kingdom
Last Funding Date:
2022-10-10
Technology:
Biopharma, Biotechnology, Health Care, Therapeutics
Estimated Revenue:
Less than $1M
Founded Date:
2019-09-01
Last Funding Type:
Series A
Total Funding:
39750000.0
Industry:
Early Drug Development